908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp Purchases 10,000 Shares

908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp bought 10,000 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were bought at an average cost of $5.60 per share, for a total transaction of $56,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 468,981 shares in the company, valued at approximately $2,626,293.60. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

908 Devices Price Performance

Shares of 908 Devices stock traded up $0.08 during midday trading on Tuesday, reaching $5.70. The company had a trading volume of 195,714 shares, compared to its average volume of 177,757. The stock has a fifty day moving average price of $6.48 and a 200 day moving average price of $7.08. 908 Devices Inc. has a fifty-two week low of $4.85 and a fifty-two week high of $12.51. The firm has a market cap of $187.99 million, a PE ratio of -5.33 and a beta of 1.02.

908 Devices (NASDAQ:MASS) last posted its quarterly earnings data on Tuesday, April 30th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.03. The company had revenue of $9.99 million during the quarter, compared to analysts’ expectations of $9.29 million. 908 Devices had a negative net margin of 68.57% and a negative return on equity of 20.47%. 908 Devices’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.39) earnings per share. As a group, sell-side analysts forecast that 908 Devices Inc. will post -1.11 EPS for the current year.

Hedge Funds Weigh In On 908 Devices

A number of institutional investors and hedge funds have recently modified their holdings of the business. ARK Investment Management LLC raised its stake in 908 Devices by 8.3% during the 4th quarter. ARK Investment Management LLC now owns 4,346,579 shares of the company’s stock worth $48,769,000 after buying an additional 333,119 shares during the period. Granahan Investment Management LLC increased its stake in 908 Devices by 10.6% during the 4th quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company’s stock valued at $22,874,000 after purchasing an additional 195,368 shares in the last quarter. Iron Triangle Partners LP lifted its stake in shares of 908 Devices by 31.1% in the fourth quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company’s stock valued at $14,417,000 after buying an additional 304,484 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of 908 Devices by 3.0% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 629,994 shares of the company’s stock valued at $4,196,000 after buying an additional 18,492 shares during the last quarter. Finally, AWM Investment Company Inc. acquired a new stake in shares of 908 Devices in the 3rd quarter worth about $3,740,000. 88.06% of the stock is currently owned by institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.